Singapore markets closed

LifeStance Health Group, Inc. (LFST)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.97-0.31 (-4.94%)
At close: 04:00PM EDT
5.97 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.10B
Enterprise value 2.16B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.88
Price/book (mrq)1.36
Enterprise value/revenue 2.97
Enterprise value/EBITDA -7.21

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-79.27%
S&P500 52-week change 3-9.13%
52-week high 329.81
52-week low 34.77
50-day moving average 37.31
200-day moving average 39.53

Share statistics

Avg vol (3-month) 3723.66k
Avg vol (10-day) 31M
Shares outstanding 5374.32M
Implied shares outstanding 6N/A
Float 870.11M
% held by insiders 115.57%
% held by institutions 183.16%
Shares short (30 May 2022) 413.55M
Short ratio (30 May 2022) 415.92
Short % of float (30 May 2022) 418.91%
Short % of shares outstanding (30 May 2022) 43.62%
Shares short (prior month 28 Apr 2022) 413.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -49.60%
Operating margin (ttm)-48.16%

Management effectiveness

Return on assets (ttm)-12.28%
Return on equity (ttm)-28.10%

Income statement

Revenue (ttm)727.47M
Revenue per share (ttm)2.15
Quarterly revenue growth (yoy)41.90%
Gross profit (ttm)233.23M
EBITDA -292.73M
Net income avi to common (ttm)-360.84M
Diluted EPS (ttm)-1.07
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)113.99M
Total cash per share (mrq)0.31
Total debt (mrq)178.7M
Total debt/equity (mrq)11.59
Current ratio (mrq)2.10
Book value per share (mrq)4.12

Cash flow statement

Operating cash flow (ttm)2.82M
Levered free cash flow (ttm)-21.25M